Featured Research

from universities, journals, and other organizations

Cranberries May Improve Chemotherapy For Ovarian Cancer

Date:
August 26, 2007
Source:
American Chemical Society
Summary:
Compounds in cranberries may help improve the effectiveness of platinum drugs that are used in chemotherapy to fight ovarian cancer, researchers have found in a controlled laboratory study. The scientists found that human ovarian cancer cells resistant to platinum drugs became up to six times more sensitized to the drugs after exposure to the cranberry compounds.

Drinking cranberry juice may help improve the effectiveness of platinum drugs that are used in chemotherapy to fight ovarian cancer, researchers report.
Credit: Courtesy of The Cranberry Institute

Compounds in cranberries may help improve the effectiveness of platinum drugs that are used in chemotherapy to fight ovarian cancer, researchers have found in a laboratory study.

Related Articles


The scientists demonstrated in cell culture studies that human ovarian cancer cells resistant to platinum drugs became up to 6 times more sensitized to the drugs after exposure to the cranberry compounds in comparison to cells that were not exposed to the compounds, which were obtained from juice extracts.

Although preliminary, the findings have the potential to save lives and reduce the harmful side effects associated with using high doses of platinum drugs for the treatment of ovarian cancer, the researchers say, adding that human studies are still needed. The new study adds to a growing number of potential health benefits linked to cranberries.

"For the first time, we have shown in our in vitro studies that cranberry extracts can sensitize resistant human ovarian cancer cell lines," say study co-presenters Ajay P. Singh, Ph.D., and Nicholi Vorsa, Ph.D., natural products chemists at Rutgers University. "This has opened up exciting possibilities for therapeutic intervention associated with platinum therapy," add Singh and Vorsa, who collaborated with colleagues Laurent Brard, M.D., Ph.D, Rakesh K. Singh, and K.S.Satyan, Ph.D., of Brown University.

But the researchers caution that the study is experimental and that patients with ovarian cancer should always consult with their physicians before trying any type of anti-cancer therapy. Ovarian cancer is the seventh most common cancer and the fifth leading cause of cancer death among women in the United States, according to the Centers for Disease Control and Prevention.

Chemotherapy using platinum drugs, including cisplatin and paraplatin, is a mainstay treatment for ovarian cancer. However, cancer cells tend to develop resistance to platinum therapy and higher doses of the drugs can cause unwanted side-effects, including nerve damage and kidney failure.

The new study focused on cranberry juice because of past research suggesting that the juice has a wide range of potential health benefits, including the ability to fight urinary tract infections, stomach ulcers, and cancer. Singh and his associates obtained ovarian cancer cells that were relatively resistant to platinum. They treated the cells with various doses of a purified extract of commercially available cranberry drink (containing 27 percent pure juice), exposed the cells to the platinum drug paraplatin and compared them to cells that were not exposed to the extract.

Paraplatin killed 6 times more cancer cells that were pre-treated with juice extract compared to cells that were exposed to the cancer drug alone, the researchers say. The extract also slowed the growth and spread of some cancer cells. The maximum amount of juice extract given to the cells was the human equivalent of about a cup of cranberry juice, according to the researchers.

Singh and colleagues believe that the active compounds in the extract are powerful antioxidants called 'A-type' proanthocyanidins that are unique to cranberries and not found in other fruits. The researchers add that they do not understand exactly how the cranberry compounds work. However, based on research by other groups, these compounds appear to bind to and block certain tumor promoter proteins found in the ovarian cancer cells, they say. The result is that the cancer cells become more vulnerable to attack from the platinum drugs, the scientists say, noting that the cranberry compounds are not a cure for cancer. 

The researchers hope to eventually identify the most active anti-cancer fractions of the cranberry extract and determine the optimal dose for effectiveness against ovarian cancer. Theoretically, a therapeutic compound made from cranberry extract could be used as part of an injectable chemotherapy regimen or as a beverage supplement to be consumed during chemotherapy, says Singh. Animal studies will begin soon and a new therapy could one day be available to consumers if further testing proves successful, he says.

For now, the researchers recommend that those with ovarian and other types of cancer seek their physician's advice for the most effective treatment options. The current study was funded by the National Institutes of Health and the Rutgers New Jersey Agricultural Experiment Station.

This research was reported at the 234th national meeting of the American Chemical Society on August 21, 2007.


Story Source:

The above story is based on materials provided by American Chemical Society. Note: Materials may be edited for content and length.


Cite This Page:

American Chemical Society. "Cranberries May Improve Chemotherapy For Ovarian Cancer." ScienceDaily. ScienceDaily, 26 August 2007. <www.sciencedaily.com/releases/2007/08/070821143625.htm>.
American Chemical Society. (2007, August 26). Cranberries May Improve Chemotherapy For Ovarian Cancer. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2007/08/070821143625.htm
American Chemical Society. "Cranberries May Improve Chemotherapy For Ovarian Cancer." ScienceDaily. www.sciencedaily.com/releases/2007/08/070821143625.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins